On November 9, 2012, he was a member of the Wujiang Science and Technology Township Youth League and Associate Professor Bai Xiaohui of Shanghai Jiaotong University. Professor of the title of “Shengyu” of Shanghai Jiaotong University, Associate Dean of School of Life Science and Technology, Shanghai Jiaotong University, Class A of the Central Organization Department "Thousand Talents Program" expert, director of Shengli Cell and Immunology Research Center, Ma Xiaojing, a tenured professor of Cornell University School of Medicine, went to Wuhu High-tech Zone to investigate and establish issues related to the "Thousand Talents Program" workstation and Suzhou Zhonglian Chemical Pharmaceutical Co., Ltd. Co., Ltd. conducted a docking negotiation.On November 9, 2012, he was a member of the Wujiang Science and Technology Township Youth League and Associate Professor Bai Xiaohui of Shanghai Jiaotong University. Professor of the title of “Shengyu” of Shanghai Jiaotong University, Associate Dean of School of Life Science and Technology, Shanghai Jiaotong University, Class A of the Central Organization Department "Thousand Talents Program" expert, director of Shengli Cell and Immunology Research Center, Ma Xiaojing, a tenured professor of Cornell University School of Medicine, went to Wuhu High-tech Zone to investigate and establish issues related to the "Thousand Talents Program" workstation and Suzhou Zhonglian Chemical Pharmaceutical Co., Ltd. Co., Ltd. conducted a docking negotiation.

Assistant General Manager Liu Yaowu of Suzhou Zhonglian Chemical Pharmaceutical Co., Ltd. introduced the development, production and technological innovation of the enterprise using PPT. Professor Ma Xiaojing introduced his research direction and major scientific and technological achievements, especially through the use of targeted drugs. The principle and market potential of the human immune system for treating tumor diseases were fully explained. The participants not only learned about the cutting-edge scientific research results of Professor Ma Xiaojing, but also took a vivid immunomedicine course.

Chairman of the Board of Directors of Suzhou Zhonglian Huang Guangsheng, Deputy Director of the Organization and Personnel Bureau of Wuhu High-tech Zone, Wang Zhiqing, and Deputy Director of the Economic Development Bureau, Bai Xiaohui, accompanied the investigation. During the investigation, Professor Ma Xiaojing visited the biomedical public service platform of the Science and Technology Park of Wuhu High-tech Zone and the research and development center of Suzhou Zhonglian.
Chairman of the Board of Directors of Suzhou Zhonglian Huang Guangsheng, Deputy Director of the Organization and Personnel Bureau of Wuhu High-tech Zone, Wang Zhiqing, and Deputy Director of the Economic Development Bureau, Bai Xiaohui, accompanied the investigation. During the investigation, Professor Ma Xiaojing visited the biomedical public service platform of the Science and Technology Park of Wuhu High-tech Zone and the research and development center of Suzhou Zhonglian.